FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the publication of Phase 1 clinical trial data ...
MediBeacon ® Transdermal GFR System is a first-in-kind product for point of care kidney function assessment Centers of Excellence ...
ARSYNL Rx Launches Exclusive HypoSpray® Transdermal Testosterone Option, Marking a New Era in Hormone Support Dover, United States – February 5, 2026 / ARSYNL Rx / ARSYNL Rx, a leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results